Press Release

Depixus in the news

We regularly participate in the world’s leading conferences on tools and technologies for biomolecular analysis and therapeutics. Look out for our presentations and come and say hello to learn more about MAGNA™ and its transformative potential for life sciences research and drug development.

The Depixus Research Program is now open: Bring the power of magnetic force spectroscopy to your research for free

23rd July 2024

The Depixus Research Program is a unique opportunity to explore the potential of single molecule interactomics in your research and see biology as it really happens.

Read More

Using MAGNA™ to explore drugs targeting RNA riboswitches

06th March 2024

We’ve been working with Dr Jay Schneekloth, a leading expert in RNA-targeted drug discovery, to use our MAGNA™ technology to probe the interactions between the PreQ1 bacterial riboswitch and its natural ligand or a synthetic small molecule.

Read More

Depixus wins SLAS2024 Ignite Award for MAGNA™ technology

12th February 2024

Paris, France – Depixus CEO Gordon Hamilton Receives The SLAS2024 Ignite Award From Judge Severine Tamas-Lhoustau, CEO Of Novoptim.

Read More

View Older News